返回成功案例
医疗健康

Biosynex has acquired Para’kito

Biosynex has acquired Para’kito, operated by Hong-Kong based Evergreen Land Ltd. The transaction includes assets and IP and the exclusive right to commercialize the brand in Europe, Africa and South America.

Created in 2005, Biosynex is a leading public health player in France and Europe. The group develops, manufactures and markets medical devices for screening, diagnosis and prevention. Biosynex is the French market leader in the design and distribution of rapid tests (RDT), commercialized in 90+ countries. The company provides its products to biology and medical analysis laboratories, hospitals, pharmacies, resellers and department stores. In 2021, the group generated over US$400 million of sales.

Launched in 2008, Para’kito is the leading European brand in the prevention and care of mosquito bites. The company provides a complete range of anti-mosquito bracelets and sprays based on 100% natural formulas, with a proprietary technology, and distributed via two channels: pharmacies and e-commerce. Para’kito is present in more than 30 countries and supplies 5,000+ pharmacies in France. In 2021, the brand generated over US$7 million of sales in Europe.

Oaklins’ team in France acted as M&A advisor to Biosynex in this transaction.

我们的服务
交易方

联系交易团队

Ludovic Beaulieu

合伙人
巴黎, 法国
Oaklins France

Quentin Boissinot

副总监
巴黎, 法国
Oaklins France

相关交易

Generali has expanded its footprint in Bulgaria by acquiring one of the top health insurers on the market
金融服务 | 医疗健康

Generali has expanded its footprint in Bulgaria by acquiring one of the top health insurers on the market

Doverie United Holding has successfully completed the sale of United Health Insurance Fund Doverie (Doverie) to Generali CEE Holding.

更多信息
Dimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.
医疗健康

Dimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.

Dimainvest S.r.l. has initiated a voluntary public tender offer for the shares of Shedir Pharma Group S.p.A.

更多信息
Afric Phar has been acquired by Pharma Capital
医疗健康

Afric Phar has been acquired by Pharma Capital

Pharma Capital S.A. has acquired a significant stake in the Moroccan pharmaceutical group Afric Phar, which includes leading companies Afric Phar, Pharmis and Partner Lab, from the Chaoui family, in one of the largest transactions in the Moroccan pharmaceutical sector.

更多信息